• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

琥珀酸二甲酯减轻脓毒症中巨噬细胞的炎症反应。

Dimethyl Itaconate Alleviates the Inflammatory Responses of Macrophages in Sepsis.

机构信息

Department of Emergency, Xingtai People's Hospital of Hebei Province, No. 16 Hongxing Street, Xingtai, 054031, Hebei, China.

Department of Reproductive Medicine, Xingtai People's Hospital of Hebei Province, No. 16 Hongxing Street, Xingtai, 054031, Hebei, China.

出版信息

Inflammation. 2021 Apr;44(2):549-557. doi: 10.1007/s10753-020-01352-4. Epub 2020 Oct 7.

DOI:10.1007/s10753-020-01352-4
PMID:33029757
Abstract

Sepsis is an inflammatory disease characterized by dysregulation of inflammation. Macrophage-mediated inflammation has been implicated in the pathophysiology of sepsis. Itaconate is a metabolite produced in activated macrophages which has anti-inflammatory activities. In the present study, we investigated the potential effects of a cell-permeable itaconate derivative dimethyl itaconate on inflammation in sepsis. We established a lipopolysaccharide (LPS)-induced septic mouse model and administered dimethyl itaconate to the septic mice. The survival rate, serum level of pro-inflammatory cytokines, and lung pathology were evaluated. We also administered dimethyl itaconate to LPS-treated bone marrow-derived macrophages (BMDMs), and measured the cytokine production and Nrf2 expression. We also evaluated the effects of dimethyl itaconate on Nrf2-deficient mice. Administration of dimethyl itaconate enhanced survival rate, decreased serum level of TNF-α and IL-6, and ameliorated lung injury in septic mice. Dimethyl itaconate also suppressed LPS-induced production of TNF-α, IL-6, and NOS2 in BMDMs. Dimethyl itaconate activated Nrf2 and promoted the expression of Nrf2 and its downstream factor HO-1 and NQO-1. The regulatory activities of dimethyl itaconate on inflammatory cytokine production, mouse survival rate were abolished in septic Nrf2 mice. Dimethyl itaconate suppressed the inflammatory responses of macrophages in sepsis.

摘要

脓毒症是一种以炎症失调为特征的炎症性疾病。巨噬细胞介导的炎症反应参与了脓毒症的病理生理学过程。衣康酸是一种在活化的巨噬细胞中产生的代谢产物,具有抗炎活性。在本研究中,我们研究了一种可渗透细胞的衣康酸衍生物-二甲基衣康酸对脓毒症炎症的潜在作用。我们建立了脂多糖(LPS)诱导的脓毒症小鼠模型,并给脓毒症小鼠施用二甲基衣康酸。评估了存活率、血清促炎细胞因子水平和肺病理。我们还将二甲基衣康酸给予 LPS 处理的骨髓来源巨噬细胞(BMDM),并测量细胞因子产生和 Nrf2 表达。我们还评估了二甲基衣康酸对 Nrf2 缺陷型小鼠的影响。二甲基衣康酸的施用提高了存活率,降低了脓毒症小鼠血清中 TNF-α和 IL-6 的水平,并改善了肺损伤。二甲基衣康酸还抑制了 LPS 诱导的 BMDM 中 TNF-α、IL-6 和 NOS2 的产生。二甲基衣康酸激活了 Nrf2,并促进了 Nrf2 及其下游因子 HO-1 和 NQO-1 的表达。在脓毒症 Nrf2 小鼠中,二甲基衣康酸对炎症细胞因子产生和小鼠存活率的调节作用被消除。二甲基衣康酸抑制了脓毒症中巨噬细胞的炎症反应。

相似文献

1
Dimethyl Itaconate Alleviates the Inflammatory Responses of Macrophages in Sepsis.琥珀酸二甲酯减轻脓毒症中巨噬细胞的炎症反应。
Inflammation. 2021 Apr;44(2):549-557. doi: 10.1007/s10753-020-01352-4. Epub 2020 Oct 7.
2
IRG1/itaconate alleviates acute liver injury in septic mice by suppressing NLRP3 expression and its mediated macrophage pyroptosis via regulation of the Nrf2 pathway.IRG1/衣康酸通过调节 Nrf2 通路抑制 NLRP3 表达及其介导的巨噬细胞焦亡来减轻脓毒症小鼠的急性肝损伤。
Int Immunopharmacol. 2024 Jun 30;135:112277. doi: 10.1016/j.intimp.2024.112277. Epub 2024 May 23.
3
Immune Response Gene-1 [IRG1]/itaconate protect against multi-organ injury via inhibiting gasdermin D-mediated pyroptosis and inflammatory response.免疫应答基因-1[IRG1]/衣康酸通过抑制 Gasdermin D 介导热激原性细胞死亡和炎症反应来防止多器官损伤。
Inflammopharmacology. 2024 Feb;32(1):419-432. doi: 10.1007/s10787-023-01278-x. Epub 2023 Jul 20.
4
4-Octyl Itaconate Activates Nrf2 Signaling to Inhibit Pro-Inflammatory Cytokine Production in Peripheral Blood Mononuclear Cells of Systemic Lupus Erythematosus Patients.衣康酸4-辛酯激活Nrf2信号通路以抑制系统性红斑狼疮患者外周血单个核细胞中促炎细胞因子的产生。
Cell Physiol Biochem. 2018;51(2):979-990. doi: 10.1159/000495400. Epub 2018 Nov 22.
5
Dimethyl itaconate protects against lippolysacchride-induced mastitis in mice by activating MAPKs and Nrf2 and inhibiting NF-κB signaling pathways.丁烯二酸盐通过激活 MAPKs 和 Nrf2 以及抑制 NF-κB 信号通路来预防脂多糖诱导的小鼠乳腺炎。
Microb Pathog. 2019 Aug;133:103541. doi: 10.1016/j.micpath.2019.05.024. Epub 2019 May 15.
6
Dimethyl itaconate, an itaconate derivative, exhibits immunomodulatory effects on neuroinflammation in experimental autoimmune encephalomyelitis.琥珀酸二甲酯,一种衣康酸衍生物,在实验性自身免疫性脑脊髓炎中对神经炎症具有免疫调节作用。
J Neuroinflammation. 2020 Apr 29;17(1):138. doi: 10.1186/s12974-020-01768-7.
7
Dimethyl itaconate alleviates the pyroptosis of macrophages through oxidative stress.二甲基丙烯酸盐通过氧化应激减轻巨噬细胞的细胞焦亡。
BMC Immunol. 2021 Nov 8;22(1):72. doi: 10.1186/s12865-021-00463-3.
8
Endogenous itaconate is not required for particulate matter-induced NRF2 expression or inflammatory response.内源性衣康酸对于颗粒物诱导的 NRF2 表达或炎症反应并非必需。
Elife. 2020 Apr 7;9:e54877. doi: 10.7554/eLife.54877.
9
A novel triptolide derivative ZT01 exerts anti-inflammatory effects by targeting TAK1 to prevent macrophage polarization into pro-inflammatory phenotype.新型雷公藤红素衍生物 ZT01 通过靶向 TAK1 防止巨噬细胞向促炎表型极化来发挥抗炎作用。
Biomed Pharmacother. 2020 Jun;126:110084. doi: 10.1016/j.biopha.2020.110084. Epub 2020 Mar 11.
10
Electrophilic properties of itaconate and derivatives regulate the IκBζ-ATF3 inflammatory axis.衣康酸及其衍生物的亲电性调节 IκBζ-ATF3 炎症轴。
Nature. 2018 Apr;556(7702):501-504. doi: 10.1038/s41586-018-0052-z. Epub 2018 Apr 18.

引用本文的文献

1
Reprogramming immunity with itaconate: metabolic mechanisms and therapeutic perspectives.用衣康酸重编程免疫:代谢机制与治疗前景
Inflamm Res. 2025 Sep 16;74(1):128. doi: 10.1007/s00011-025-02087-4.
2
Itaconic Acid: A Regulator of Immune Responses and Inflammatory Metabolism.衣康酸:免疫反应和炎症代谢的调节剂
Curr Issues Mol Biol. 2025 Jul 9;47(7):534. doi: 10.3390/cimb47070534.
3
4-Octyl Itaconate Modulates Dendritic Cells Function and Tumor Immunity via NRF2 Activation.衣康酸4-辛酯通过激活NRF2调节树突状细胞功能和肿瘤免疫。

本文引用的文献

1
Mesenchymal stem cell-based FGF2 gene therapy for acute lung injury induced by lipopolysaccharide in mice.基于间充质干细胞的FGF2基因疗法对小鼠脂多糖诱导的急性肺损伤的作用
Eur Rev Med Pharmacol Sci. 2015;19(5):857-65.
2
Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray.通过寡核苷酸微阵列鉴定化学预防剂萝卜硫素诱导的Nrf2调控基因。
Cancer Res. 2002 Sep 15;62(18):5196-203.
3
Cytokines in innate and adaptive immunity.先天免疫和适应性免疫中的细胞因子。
J Inflamm Res. 2025 Apr 28;18:5699-5713. doi: 10.2147/JIR.S516085. eCollection 2025.
4
Dimethyl Itaconate Alleviates Escherichia coli-Induced Endometritis Through the Guanosine-CXCL14 Axis via Increasing the Abundance of norank_f_Muribaculaceae.衣康酸二甲酯通过增加无分类的毛螺菌科丰度,经由鸟苷-CXCL14轴减轻大肠杆菌诱导的子宫内膜炎。
Adv Sci (Weinh). 2025 Jun;12(21):e2414792. doi: 10.1002/advs.202414792. Epub 2025 Apr 14.
5
The potential immunological mechanisms of sepsis.脓毒症的潜在免疫学机制。
Front Immunol. 2024 Jul 8;15:1434688. doi: 10.3389/fimmu.2024.1434688. eCollection 2024.
6
Metabolic Reprogramming via ACOD1 depletion enhances function of human induced pluripotent stem cell-derived CAR-macrophages in solid tumors.通过 ACOD1 耗竭进行代谢重编程可增强人诱导多能干细胞衍生的 CAR-巨噬细胞在实体瘤中的功能。
Nat Commun. 2023 Sep 18;14(1):5778. doi: 10.1038/s41467-023-41470-9.
7
Carvacrol protects mice against LPS-induced sepsis and attenuates inflammatory response in macrophages by modulating the ERK1/2 pathway.香芹酚通过调节 ERK1/2 通路保护 LPS 诱导脓毒症的小鼠并减轻巨噬细胞的炎症反应。
Sci Rep. 2023 Aug 7;13(1):12809. doi: 10.1038/s41598-023-39665-7.
8
Immune Response Gene-1 [IRG1]/itaconate protect against multi-organ injury via inhibiting gasdermin D-mediated pyroptosis and inflammatory response.免疫应答基因-1[IRG1]/衣康酸通过抑制 Gasdermin D 介导热激原性细胞死亡和炎症反应来防止多器官损伤。
Inflammopharmacology. 2024 Feb;32(1):419-432. doi: 10.1007/s10787-023-01278-x. Epub 2023 Jul 20.
9
Itaconate family-based host-directed therapeutics for infections.基于衣康酸家族的宿主导向治疗感染的药物。
Front Immunol. 2023 May 16;14:1203756. doi: 10.3389/fimmu.2023.1203756. eCollection 2023.
10
Skeletal myotube-derived extracellular vesicles enhance itaconate production and attenuate inflammatory responses of macrophages.骨骼肌肌管衍生的细胞外囊泡增强了衣康酸盐的产生,并减轻了巨噬细胞的炎症反应。
Front Immunol. 2023 Mar 2;14:1099799. doi: 10.3389/fimmu.2023.1099799. eCollection 2023.
Rev Immunogenet. 2000;2(3):359-73.